Johnson & Johnson edges toward its 52-week high, but investors face valuation and pipeline questions
A market-focused report says Johnson & Johnson’s stock is up more than 50% over the past year and is nearing its 52-week peak. The same analysis points to potential pressure points, including how richly the shares are priced, what insider trading suggests, and how the company’s product pipeline could shape results.